Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Treasury Shares: 2011-2019

Historic Treasury Shares for Gyre Therapeutics (GYRE) over the last 3 years, with Sep 2019 value amounting to $1.6 million.

  • Gyre Therapeutics' Treasury Shares rose 19.01% to $1.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.6 million, marking a year-over-year increase of 19.01%. This contributed to the annual value of $821,741 for FY2017, which is 482.84% up from last year.
  • As of Q3 2019, Gyre Therapeutics' Treasury Shares stood at $1.6 million, which was down 4.76% from $1.6 million recorded in Q2 2019.
  • Gyre Therapeutics' 5-year Treasury Shares high stood at $1.6 million for Q2 2019, and its period low was $44,704 during Q1 2017.
  • Moreover, its 3-year median value for Treasury Shares was $1.1 million (2018), whereas its average is $1.1 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first slumped by 79.89% in 2015, then spiked by 2,195.98% in 2018.
  • Over the past 5 years, Gyre Therapeutics' Treasury Shares (Quarterly) stood at $103,129 in 2015, then soared by 36.71% to $140,990 in 2016, then soared by 482.84% to $821,741 in 2017, then soared by 70.87% to $1.3 million in 2018, then rose by 19.01% to $1.6 million in 2019.
  • Its Treasury Shares was $1.6 million in Q3 2019, compared to $1.6 million in Q2 2019 and $1.6 million in Q1 2019.